New York Life Investment Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-155,036
| Closed | -$371K | – | 947 |
|
|
2024
Q1 | $371K | Buy |
155,036
+105,079
| +210% | +$251K | ﹤0.01% | 974 |
|
|
2023
Q4 | $166K | Sell |
49,957
-2,096
| -4% | -$6.98K | ﹤0.01% | 1298 |
|
|
2023
Q3 | $195K | Sell |
52,053
-8,201
| -14% | -$30.7K | ﹤0.01% | 1275 |
|
|
2023
Q2 | $257K | Sell |
60,254
-12,650
| -17% | -$54K | ﹤0.01% | 1269 |
|
|
2023
Q1 | $499K | Buy |
+72,904
| New | +$499K | 0.01% | 679 |
|